Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epitranscriptomic Biomarkers for Ischemic Heart Disease (IHD-EPITRAN) - A Prospective Cohort Study

NCT04533282 is registered in ClinicalTrials.gov with Hospital District of Helsinki and Uusimaa as lead sponsor.

NCT NCT04533282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04533282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epitranscriptomic Biomarkers for Ischemic Heart Disease (IHD-EPITRAN) - A Prospective Cohort Study
Lead sponsor
Hospital District of Helsinki and Uusimaa
Phase
Observational
Overall status
Unknown status
Start date
November 10, 2020
Completion date
December 31, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, aortic valve stenosis, coronary artery disease, ischemic heart disease